• 제목/요약/키워드: Alanine aminotransferase(ALT)

검색결과 666건 처리시간 0.023초

Screening of Hepatoprotective Activity of Medicinal Plant Extracts on Carbon Tetrachloride-induced Hepatotoxicity in Rats

  • Jeong, Choon-Sik;Suh, In-Ok;Hyun, Jin-Ee;Lee, Eun-Bang
    • Natural Product Sciences
    • /
    • 제9권2호
    • /
    • pp.87-90
    • /
    • 2003
  • The purpose of this study was to find the effect of 36 traditional medicinal plant species on hepatoprotective activity screening. For this study, carbon tetrachloride $(CCl_{4})$ intoxificated rats were used. Test extracts were made with the traditional medicinal plants refluxed in 95% MeOH and orally administered to the rats. Sixteen species, such as Mentha arvensis, Sophora japonica, Benincasa hispida, Lonicera japonica (Lonicerae Flos), Agaricus blazei, Epimedium koreanum, Aralia continentalis, Lithospermum erythrorhizon, Cimicifuga foetida, Gastrodia elata, Sanguisorba officinalis, Cephalonoplos segetum, Bupleurum falcatum, Alisma plantago-aquatica var. orientale, Lonicera japonica (Lonicerae Folium) and Sinomenium acutum showed protective effect against increased serum alanine aminotransferase (ALT) and/or serum asparteate aminotransferase (AST) activities.

Benzo$(\alpha)pyrene$에 의해 유도된 흰쥐의 간 장해에 미치는 강활 Methanol 추출물의 효과 (Effects of Methanolic Extract of Angelicae koreana Radix against Benzo$(\alpha)pyrene$ Induced Liver Injury in Rats)

  • 윤수홍;하헌
    • 동아시아식생활학회지
    • /
    • 제15권5
    • /
    • pp.619-622
    • /
    • 2005
  • To evaluate the preventive effects of methanolic extract of Angelica koreana(MEAK), this extract was given to rats orally at various doses of 10, 50 and 100 mg/kg before hepatotoxicant, benzo$(\alpha)pyrene$ treatment The increased serum enzyme levels of aspartate aminotransferase (AST), alanine aminotransferase(ALT) and alkaline phosphatase(ALP) by benzo$(\alpha)pyrene$ induction were significantly lowered in a dose dependent manner after pretreatment with MEAK. Furthermore, MEAK also decreased the elevated lipid levels after benzo$(\alpha)pyrene$ administration. These results revealed that MEAK could afford a significant protective action in the alleviation of benzoBenzo$(\alpha)pyrene$ induced hepatocellular injury.

  • PDF

Protective Effect of Sachungwhan against CCl4-induced Hepatotoxicity

  • Koo, Ja-Young;Jung, Ki-Hwa
    • Biomolecules & Therapeutics
    • /
    • 제14권4호
    • /
    • pp.207-215
    • /
    • 2006
  • Sachungwhan reduced hepatotoxicity induced by carbon tetrachloride($CCl_4$). Improved liver function was observed by measuring the activities of aspartate aminotransferase(AST), alanine aminotransferase(ALT), alkaline phosphatase(ALP), blood urea nitrogen(BUN), creatinine(CRE), total cholesterol(TCHO), triglyceride(TG), low density lipoprotein cholesterol(LDL-CHO), high density lipoprotein cholesterol(HDL-CHO), total protein(TP), albumin(ALB) and total bilirubin(BIL) in serum. Hepatic parameters monitored were levels of cholesterol(CHO), triglyceride(TG), malondialdehyde(MDA), content of cytochrome P450(CYP), level of glutathione(GSH), and activities of NADPH-CYP reductase, superoxide dismutase(SOD), catalase(CAT), glutathione S-transferase(GST), glutathione reductase(GR), glutathione peroxidase(GPx). The histopathological examination showed that the treatment of Sachungwhan relieved the ballooning degeneration of hepatocytes which had been generated by $CCl_4$. The results suggested that hepatoprotective effects of Sachungwhan possibly are due to their promising antioxidative activity.

A chemical proteomic approach for in vivo evaluation of CCl4 effect on the acute serum proteins.

  • Uhm, Young-Ho;Kim, Young-Doo;Seo, Eun-Seok;Kang, Tae-Hyuk;Kang, Dong-Hoon;Soh, Yun-Jo;Kang, Chul-Hun
    • 대한약학회:학술대회논문집
    • /
    • 대한약학회 2003년도 Proceedings of the Convention of the Pharmaceutical Society of Korea Vol.1
    • /
    • pp.254.1-254.1
    • /
    • 2003
  • CCl4 has been known as typical chemical which induce acute hepatitis accompanying increase in the levels of acute phase proteins in serum. In this study, after acute liver damage was induced by CCl4 in Sprague-Dawley rats, the levels of serum acute phase proteins were examined using 2-dimensional electrophoresis and lactic dehydrogenase (LDH), alanine aminotransferase (ALT) and aspartate aminotransferase (AST) levels in blood were also examined at 1, 2, 3 days after the induction to confirm acute hepatitis. (omitted)

  • PDF

Lamivudine Therapy Exacerbates Bilirubinemia in Patients Underlying Severely Advanced Hepatitis

  • Choi, Young Hee;Lee, Chang Ho;Ko, Myong Suk;Han, Hyun Joo;Kim, Sang Geon
    • Toxicological Research
    • /
    • 제33권4호
    • /
    • pp.343-350
    • /
    • 2017
  • Lamivudine belongs to the set of antiviral agents effective against hepatitis B virus infection. Given case reports on liver injuries after certain antiviral agent treatments, this study examined the effects of lamivudine on alanine aminotransferase (ALT) and total bilirubin (TB) using a medical system database. A total of 1,321 patients taking lamivudine alone or with others were evaluated using laboratory hits in an electronic medical system at Seoul National University Hospital from 2005 through 2011. The patients were grouped according to prior ALT results: G#1, ALT < 40 IU/L; G#2, 40 IU/L ${\leq}$ ALT < 120 IU/L; G#3, 120 IU/L ${\leq}$ ALT < 240 IU/L; and G#4, ALT ${\geq}$ 240 IU/L. In G#1 and G#2 patients, lamivudine or adefovir treatment decreased ALT and TB compared to prior values. In G#3 and G#4 patients with three times the upper limit of normal (ULN) ${\leq}$ ALT < 15 times the ULN, both ALT and TB were decreased after treatment with lamivudine alone, or adefovir following lamivudine therapy, indicating that lamivudine therapy ameliorated liver functions. However, in G#4 patients who experienced severely advanced hepatitis (ALT ${\geq}$ 15 times the ULN, or ${\geq}$ 600 IU/L), lamivudine augmented TBmax ($6.3{\rightarrow}13.3mg/dL$) despite a slight improvement in ALT ($839{\rightarrow}783IU/L$), indicative of exacerbation of bilirubinemia. Patients who used adefovir after lamivudine also showed a high incidence of hyperbilirubinemia when they experienced severely advanced hepatitis. Treatment with adefovir alone did not show the effect. In conclusion, lamivudine may increase the risk of hyperbilirubinemia in patients with severely advanced hepatitis, implying that caution should be exercised when using lamivudine therapy in certain patient populations.

흰쥐에 있어서 주정중독이 Bromobenzene 대사에 미치는 영향 (Effect of Ethanol Pretreatment on the Bromobenzene Metabolism in Rats)

  • 김중우;신중규;윤종국
    • Toxicological Research
    • /
    • 제11권2호
    • /
    • pp.253-259
    • /
    • 1995
  • To investigate an effect of ethanol pretreatment on the bromobenzene metabolism, the brornobenzene (400 mg/kg body wt. i. p.) was given 3 times at intervals of one day to the male rats orally pretreated with 5% ethanol throughout 2 months. In the ethanol pretreated rats, liver injuries were not demonstrated on the basis of the liver weight per body weight, serum levels of alanine aminotransferase (ALT) activity and histopathologic findings. By the bromobenzene treatment, ethanol pretreated rats showed the more decreased levels of serum ALT and liver weight/body weight(%), and decreased degree of liver damage on histopathological observation than the control group. The ethanol pretreated rats showed the more increased activities of hepatic aniline hydroxylase, glutathione Stransf erase (GST) and the more decreased contents of glutathione than the control. Concomitantly the ethanol pretreated rats showed the more decreased contents of hepatic glutathione and increased activities of GST by the bromobenzene treatment. Above results indicate that ethanol pretreatment enhance the metabolizing ability of bromobenzene in rats.

  • PDF

Mercury Exposure in Association With Decrease of Liver Function in Adults: A Longitudinal Study

  • Choi, Jonghyuk;Bae, Sanghyuk;Lim, Hyungryul;Lim, Ji-Ae;Lee, Yong-Han;Ha, Mina;Kwon, Ho-Jang
    • Journal of Preventive Medicine and Public Health
    • /
    • 제50권6호
    • /
    • pp.377-385
    • /
    • 2017
  • Objectives: Although mercury (Hg) exposure is known to be neurotoxic in humans, its effects on liver function have been less often reported. The aim of this study was to investigate whether total Hg exposure in Korean adults was associated with elevated serum levels of the liver enzymes aspartate aminotransferase (AST), alanine transaminase (ALT), and gamma-glutamyltransferase (GGT). Methods: We repeatedly examined the levels of total Hg and liver enzymes in the blood of 508 adults during 2010-2011 and 2014-2015. Cross-sectional associations between levels of blood Hg and liver enzymes were analyzed using a generalized linear model, and nonlinear relationships were analyzed using a generalized additive mixed model. Generalized estimating equations were applied to examine longitudinal associations, considering the correlations of individuals measured repeatedly. Results: GGT increased by 11.0% (95% confidence interval [CI], 4.5 to 18.0%) in women and 8.1% (95% CI, -0.5 to 17.4%) in men per doubling of Hg levels, but AST and ALT were not significantly associated with Hg in either men or women. In women who drank more than 2 or 3 times per week, AST, ALT, and GGT levels increased by 10.6% (95% CI, 4.2 to 17.5%), 7.7% (95% CI, 1.1 to 14.7%), and 37.5% (95% CI,15.2 to 64.3%) per doubling of Hg levels, respectively, showing an interaction between blood Hg levels and drinking. Conclusions: Hg exposure was associated with an elevated serum concentration of GGT. Especially in women who were frequent drinkers, AST, ALT, and GGT showed a significant increase, with a significant synergistic effect of Hg and alcohol consumption.

야생 산사(Crataegus pinnatifida Bunge)가 이상지질혈증 흰쥐의 간 기능 대사효소의 활성 변화에 미치는 영향 (Effects of Feral Haw (Crataegus pinnatifida Bunge) on Hepatic Functional Enzyme Activity in Dyslipidemic Rats)

  • 성종환;김민아;;김한수;이영근;김동섭;정헌식
    • 동아시아식생활학회지
    • /
    • 제24권2호
    • /
    • pp.176-182
    • /
    • 2014
  • 산사(Crataegus pinnatifida Bunge) 중의 생리활성물질이 이상지질혈증에 있어서 간 조직 및 간 기능 대사효소의 활성 변화 등에 생리적 효능이 있을 것으로 판단되어 Sprague Dawley계 수컷 흰쥐를 이용하여 실험을 수행하였다. 대조군인 NND군, 대조군에 산사 추출물을 섭취시킨 NNDH 군, 이상지질혈증군인 CDD 군, 이상지질혈증군에 산사 추출물을 섭취시킨 DDH 군으로 나누어 5주간 실험 사육하였다. ALP(alkaline phosphatase), LDH(lactate dehydrogenase), AST(aspartate aminotransferase) 및 ALT(alanine aminotransferase) 활성은 모두 동일한 경향을 나타내었다. NND 군과 NNDH 군 간에는 유의적인 차이가 없었다. 이상지질혈증군인 CDD 군이 가장 높은 활성을 보였고, 이상지질혈증군에 산사 추출물을 섭취시킨 DDH 군에서 감소하는 것으로 나타났다. 간장의 조직학적 검사는 NND 군과 NNDH 군에서는 어떠한 이상 소견도 발견하지 못하였으나, CDD 군에서 지방 세포의 수와 크기증가, 지방 변성 및 염증 세포 등이 관찰되었고, DDH 군에서 지방 세포의 수와 크기가 줄어들었으며, 지방 변성 등이 감소된 것을 관찰할 수 있었다. 따라서 산사 추출물은 지방세포 분화 억제 및 지방 분해 작용과 간 기능 개선 효과 있는 것으로 추정되며, 간 보호 기능성 물질로서 활용 가능성이 우수할 것으로 사료된다.

대사에너지가 열 스트레스에 노출된 오리의 혈액 생체지표에 미치는 영향 (Influence of metabolizable energy on blood biomarkers in duck under heat stress)

  • 심준보;최두형;김창래;박병성
    • 한국응용과학기술학회지
    • /
    • 제34권1호
    • /
    • pp.132-141
    • /
    • 2017
  • 본 연구의 목표는 열 스트레스 하에서 오리사료 내 대사에너지(ME) 수준이 혈액 매개변수에 미치는 영향을 조사하는 것이었다. 총 240마리의 육용 오리 채리밸리((Anas platyrhynchos)를 4처리구로 완전임의배치 한 후 42일 동안 사육하였다. 처리구는 ME 2900 kcal/kg, ME 3000 kcal/kg, ME 3100 kcal/kg 및 ME 3200 kcal/kg로 구분하였다. 혈액 지질 프로파일은 ME 3000과 비교할 때 ME 2900이 높았으나 ME 3100과 ME 3200은 낮았다 (p < 0.05). 혈액 aspartate aminotransferase (AST)와 alanine aminotransferase (ALT) 수준은 ME 3000과 비교할 때 ME 3100과 ME 3200에서 증가하였다 (p < 0.05). 혈액 적혈구와 혈소판 프로파일은 ME 3000과 비교할 때 ME 3100과 ME 3200은 높아졌으나 ME 2900은 감소하였다 (p < 0.05). 혈액 전해질 가운데, chloride ($Cl^-$) 농도는 ME 3000과 비교할 때 ME 2900에서 낮아졌다 (p < 0.05). 혈액 가스와 $PCO_2$는 ME 3000과 비교할 때 ME 2900에서 감소하였다 (p < 0.05). 혈액 면역물질(IgG) 수준은 ME 3000과 비교할 때 ME 2900에서 줄어들었다 (p < 0.05). 스트레스 호르몬, 코르티코스테론은 ME 3000과 비교할 때 ME 2900에서 높아졌으나 ME 3100과 ME 3200은 낮아졌다 (p < 0.05).

랫드에서 혈액지질 감소에 관한 오메가 6와 3 지방산 비율의 생화학적 메카니즘 (Biochemical mechanism of the ratio of omega 6 to 3 fatty acid on blood lipid reduction in rats)

  • 이승형;김진수;최두형;김창래;엄경환;박병성
    • 한국응용과학기술학회지
    • /
    • 제34권2호
    • /
    • pp.315-326
    • /
    • 2017
  • 본 연구는 차세대 랫드에서 혈액 지질 감소에 관한 식이 내 오메가 6와 3 지방산 비율의 생화학적 메카니즘을 조사하였다. 실험처리군은 오메가 6:오메가 3비율 0 (대조구), 1:1, 8:1, 19:1로 구분하였다. 혈액 중성지방, 총콜레스테롤, 저밀도지질단백질(LDL-C), aspartate aminotransferase (AST), alanine aminotransferase (ALT), glucose의 수준은 오메가 6:오메가 3 비율 1:1 그룹에서 가장 낮았다. 혈액 고밀도지질단백질(HDL-C), 인지질의 수준은 오메가 6:오메가 3 비율 1:1 그룹이 가장 높았다. HMG-CoA reductase activity는 전체 저리구 가운데 오메가 6:오메가 3 비율 1:1, 8:1 그룹에서 가장 강하게 억제되었으나 분을 통한 스테롤의 배설량은 촉진되었다. 혈액 오메가 6:오메가 3 비율은 섭취한 식이 내 오메가 6:오메가 3 비율 증가에 따른 농도 의존적으로 감소하였다. 본 연구결과는 부모 세대로부터 차세대 랫드에 이르기까지 오메가 6:오메가 3 비율이 8:1 이하로 낮아진 식이를 섭취하면 영양소 대사작용 활성화 메카니즘에 의한 혈액 중 유해지질 감소, 간 기능 유지 및 성장을 자극한다는 새로운 사실을 나타낸다.